Fidelity Investments’s Meridian Bioscience Inc VIVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,753
| Closed | -$91.4K | – | 5655 |
|
|
2022
Q4 | $91.4K | Sell |
2,753
-214,400
| -99% | -$6.91M | ﹤0.01% | 3245 |
|
|
2022
Q3 | $6.85M | Sell |
217,153
-1,733,834
| -89% | -$56.1M | ﹤0.01% | 2054 |
|
|
2022
Q2 | $59.4M | Buy |
1,950,987
+1,338,620
| +219% | +$36.2M | 0.01% | 1184 |
|
|
2022
Q1 | $15.9M | Sell |
612,367
-53,159
| -8% | -$1.26M | ﹤0.01% | 1897 |
|
|
2021
Q4 | $13.6M | Sell |
665,526
-155
| -0% | -$2.97K | ﹤0.01% | 1992 |
|
|
2021
Q3 | $12.8M | Buy |
665,681
+244,979
| +58% | +$4.88M | ﹤0.01% | 2022 |
|
|
2021
Q2 | $9.33M | Sell |
420,702
-486,959
| -54% | -$10.3M | ﹤0.01% | 2132 |
|
|
2021
Q1 | $23.8M | Sell |
907,661
-289,863
| -24% | -$6.89M | ﹤0.01% | 1732 |
|
|
2020
Q4 | $22.4M | Sell |
1,197,524
-114,181
| -9% | -$2.13M | ﹤0.01% | 1671 |
|
|
2020
Q3 | $22.3M | Buy |
1,311,705
+201,616
| +18% | +$3.92M | ﹤0.01% | 1514 |
|
|
2020
Q2 | $25.9M | Buy |
1,110,089
+847,376
| +323% | +$12.3M | ﹤0.01% | 1443 |
|
|
2020
Q1 | $2.21M | Buy |
262,713
+35,697
| +16% | +$301K | ﹤0.01% | 2169 |
|
|
2019
Q4 | $2.22M | Buy |
227,016
+1
| +0% | +$9 | ﹤0.01% | 2232 |
|
|
2019
Q3 | $2.15M | Buy |
227,015
+69,656
| +44% | +$734K | ﹤0.01% | 2251 |
|
|
2019
Q2 | $1.87M | Buy |
157,359
+156,149
| +12,905% | +$1.88M | ﹤0.01% | 2340 |
|
|
2019
Q1 | $22K | Sell |
1,210
-332
| -22% | -$5.52K | ﹤0.01% | 2958 |
|
|
2018
Q4 | $27K | Buy |
1,542
+179
| +13% | +$3.05K | ﹤0.01% | 2839 |
|
|
2018
Q3 | $20K | Buy |
+1,363
| New | +$21.1K | ﹤0.01% | 3003 |
|
|
2017
Q4 | – | Sell |
-284,578
| Closed | -$4.07M | – | 2721 |
|
|
2017
Q3 | $4.07M | Sell |
284,578
-68,563
| -19% | -$980K | ﹤0.01% | 2196 |
|
|
2017
Q2 | $5.56M | Hold |
353,141
| – | – | ﹤0.01% | 2142 |
|
|
2017
Q1 | $4.87M | Buy |
353,141
+211,023
| +148% | +$2.95M | ﹤0.01% | 2177 |
|
|
2016
Q4 | $2.52M | Buy |
+142,118
| New | +$2.5M | ﹤0.01% | 2336 |
|
|
2015
Q2 | – | Sell |
-2,141,017
| Closed | -$40.9M | – | 2828 |
|
|
2015
Q1 | $40.9M | Sell |
2,141,017
-1,328,730
| -38% | -$24.6M | 0.01% | 1421 |
|
|
2014
Q4 | $57.1M | Sell |
3,469,747
-14,957
| -0.4% | -$257K | 0.01% | 1268 |
|
|
2014
Q3 | $61.6M | Buy |
3,484,704
+3,236,977
| +1,307% | +$63.6M | 0.01% | 1202 |
|
|
2014
Q2 | $5.11M | Buy |
+247,727
| New | +$5.09M | ﹤0.01% | 2237 |
|
|
2014
Q1 | – | Sell |
-513,170
| Closed | -$13.6M | – | 2733 |
|
|
2013
Q4 | $13.6M | Buy |
+513,170
| New | +$12.6M | ﹤0.01% | 1861 |
|
Other funds holding VIVO
Fidelity Investments's VIVO Position: Q1 2023 in Review
Fidelity Investments sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 2,753 shares — an estimated $91.4K sold.
Fidelity Investments first reported a position in VIVO in Q4 2013 and held it in 27 quarters. The position peaked at $61.6M in Q3 2014. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.
- Fidelity Investments reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
- Fidelity Investments sold 2,753 Meridian Bioscience Inc shares in Q1 2023, an estimated $91.4K.
- Fidelity Investments first reported a position in Meridian Bioscience Inc in Q4 2013 and held it in 27 quarters.
- Fidelity Investments's Meridian Bioscience Inc position peaked at $61.6M in Q3 2014.
- 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.
Based on Fidelity Investments's 13F filing for Q1 2023, filed 11 May 2023.